Rempex Pharmaceuticals Inc - 92121 San Diego, CA

Business Name: Rempex Pharmaceuticals Inc
Categorized In: Commercial Medical Research
Address: 11535 Sorrento Valley Road # 401, San Diego, CA 92121
Phone Number: (858) 875-2840
Contact Person: Daniel Burgess, Chief Executive Officer
Website Address: rempexpharma.com
NAICS Code: 4242101
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2004
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $50.000.000 to $99.999.999
Share This Business:
Similar Businesses: Medivas LLC - San Diego, CA 92121
Acea Biosciences Inc - San Diego, CA 92121
Bio-Quant Inc - San Diego, CA 92121
Cylene Pharmaceuticals - San Diego, CA 92121
Krex Pharmaceuticals Inc - San Diego, CA 92121
Advanced Biodelivery Sciences - San Diego, CA 92121
S K S Ocular LLC - San Diego, CA 92121
Tenova Pharmaceuticals Inc - San Diego, CA 92121
Stemedica Cell Technology - San Diego, CA 92121
Gnf Commercial Systems - San Diego, CA 92121
Sage Bioventures Inc - San Diego, CA 92121
Biomedica Inc - San Diego, CA 92121
Helicon Therapeutics - San Diego, CA 92121
Celgene Research San Diego - San Diego, CA 92121
Targegen Inc - San Diego, CA 92121
Astute Medical Inc - San Diego, CA 92121

Rempex Pharmaceuticals Inc provides professional Commercial Medical Research from its single location at the coordinates 32.9117,-117.23134.

The company offers B2B variables under the SIC code 8731 and NAICS code 4242101, while making an annual revenue of $50.000.000 to $99.999.999 and hiring a total of 1 to 4 employees.

Founded in 2004, the company can now be visited at 11535 Sorrento Valley Road # 401, San Diego, California 92121 or contacted through representative Daniel Burgess, Chief Executive Officer at (858) 875-2840.

For frequently asked questions and further inquiries about professional Commercial Medical Research, get to know more about Rempex Pharmaceuticals Inc through its company website at rempexpharma.com. Engage with this business on its social media platforms through on Twitter and on Facebook.